Mature breast adipocytes promote breast cancer cell motility

Experimental and Molecular Pathology

Volumn 92, Issue 3, 2012, Pages 312-317

  Carter, Jennifer C ^a,b   Church, Frank C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adipocyte; Breast cancer; Cell motility; Plasminogen activator inhibitor 1; Urokinase

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; UROKINASE;

ADIPOCYTE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER CELL; CANCER GROWTH; CELL ADHESION; CELL MATURATION; CELL MOTILITY; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; DNA MICROARRAY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ASSOCIATION; METASTASIS; OMENTUM; PROADIPOCYTE; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ADIPOCYTES; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OMENTUM; PHOSPHORYLATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84859183441     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.03.005     Document Type: Article

References (45)

1. Ahn J., Schatzkin A., Lacey J.V., Albanes D., Ballard-Barbash R., Adams K.F., Kipnis V., Mouw T., Hollenbeck A.R., Leitzmann M.F. Adiposity, adult weight change, and postmenopausal breast cancer risk. Archives of Internal Medicine 2007, 167:2091-2102.
2. Alessi M.C., Bastelica D., Morange P., Berthet B., Leduc I., Verdier M., Geel O., Juhan-Vague I. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 2000, 49:1374-1380.
3. Bahia L., Aguiar L.G., Villela N., Bottino D., Godoy-Matos A.F., Geloneze B., Tambascia M., Bouskela E. Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics (São Paulo, Brazil) 2006, 61:433-440.
4. Bastelica D., Morange P., Berthet B., Borghi H., Lacroix O., Grino M., Juhan-Vague I., Alessi M.C. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arteriosclerosis, Thrombosis, and Vascular Biology 2002, 22:173-178.
5. Carter J.C., Church F.C. Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-gamma and plasminogen activator inhibitor-1. PPAR Research 2009, 2009:345320.
6. Carter J.C., Church F.C. Peroxisome proliferator-activated receptor-gamma ligands alter breast cancer cell motility through modulation of the plasminogen activator system. Journal of Oncology 2011, 2011:594258.
7. Carter J.C., Campbell R.A., Gibbons J.A., Gramling M.W., Wolberg A.S., Church F.C. Enhanced cell-associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cells. Journal of Thrombosis and Haemostasis 2010, 8:1323-1332.
8. Casbas-Hernandez P., Fleming J.M., Troester M.A. Gene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma. Journal of Biomedicine and Biotechnology 2011, 2011:520987.
9. Chamras H., Bagga D., Elstner E., Setoodeh K., Koeffler H.P., Heber D. Preadipocytes stimulate breast cancer cell growth. Nutrition and Cancer 1998, 32:59-63.
10. Chandrasekar N., Mohanam S., Gujrati M., Olivero W.C., Dinh D.H., Rao J.S. Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene 2003, 22:392-400.
11. Cichon M.A., Degnim A.C., Visscher D.W., Radisky D.C. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. Journal of Mammary Gland Biology and Neoplasia 2010, 15:389-397.
12. Costantini V., Sidoni A., Deveglia R., Cazzato O.A., Bellezza G., Ferri I., Bucciarelli E., Nenci G.G. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues. Cancer 1996, 77:1079-1088.
13. Crandall D.L., Quinet E.M., Morgan G.A., Busler D.E., McHendry-Rinde B., Kral J.G. Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes. Journal of Clinical Endocrinology and Metabolism 1999, 84:3222-3227.
14. Dirat B., Bochet L., Dabek M., Daviaud D., Dauvillier S., Majed B., Wang Y.Y., Meulle A., Salles B., Le Gonidec S., Garrido I., Escourrou G., Valet P., Muller C. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Research 2011, 71:2455-2465.
15. duPre S.A., Redelman D., Hunter K.W. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis. Experimental and Molecular Pathology 2008, 85:174-188.
16. Festuccia C., Gravina G.L., Muzi P., Millimaggi D., Dolo V., Vicentini C., Bologna M. Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors. Prostate 2008, 68:965-974.
17. Flegal K.M., Carroll M.D., Kit B.K., Ogden C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. Journal of the American Medical Association 2012, 307:491-497.
18. Galaria I.I., Nicholl S.M., Roztocil E., Davies M.G. Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation. Journal of Surgical Research 2005, 127:46-52.
19. Gramling M.W., Church F.C. Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment. Thrombosis Research 2010, 125:377-381.
20. Gutierrez L.S., Schulman A., Brito-Robinson T., Noria F., Ploplis V.A., Castellino F.J. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Research 2000, 60:5839-5847.
21. Hatano E., Brenner D.A. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation. American Journal of Physiology - Gastrointestinal and Liver Physiology 2001, 281:G1357-G1368.
22. Hildenbrand R., Schaaf A. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. International Journal of Oncology 2009, 34:15-23.
23. Iyengar P., Espina V., Williams T.W., Lin Y., Berry D., Jelicks L.A., Lee H., Temple K., Graves R., Pollard J., Chopra N., Russell R.G., Sasisekharan R., Trock B.J., Lippman M., Calvert V.S., Petricoin E.F., Liotta L., Dadachova E., Pestell R.G., Lisanti M.P., Bonaldo P., Scherer P.E. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. The Journal of Clinical Investigation 2005, 115:1163-1176.
24. Johnston P.G., Rondinone C.M., Voeller D., Allegra C.J. Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line. Cancer Research 1992, 52:6860-6865.
25. Juhan-Vague I., Alessi M.C., Morange P.E. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Annals of Medicine 2000, 32(Suppl. 1):78-84.
26. Kanaya A.M., Wassel Fyr C., Vittinghoff E., Harris T.B., Park S.W., Goodpaster B.H., Tylavsky F., Cummings S.R. Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1. Archives of Internal Medicine 2006, 166:350-356.
27. Kaposi-Novak P., Libbrecht L., Woo H.G., Lee Y.H., Sears N.C., Coulouarn C., Conner E.A., Factor V.M., Roskams T., Thorgeirsson S.S. Central role of c-Myc during malignant conversion in human hepatocarcinogenesis. Cancer Research 2009, 69:2775-2782.
28. Kim C., Park J., Kang E., Ahn C., Cha B., Lim S., Kim K., Lee H. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity. Obesity (Silver Spring) 2006, 14:1164-1171.
29. Kulik G., Klippel A., Weber M.J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Molecular and Cellular Biology 1997, 17:1595-1606.
30. Laidler P., Dulinska J., Mrozicki S. Does the inhibition of c-myc expression mediate the anti-tumor activity of PPAR's ligands in prostate cancer cell lines?. Archives of Biochemistry and Biophysics 2007, 462:1-12.
31. Lebret S.C., Newgreen D.F., Thompson E.W., Ackland M.L. Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors. Breast Cancer Research 2007, 9:R19.
32. Leitzmann M.F., Koebnick C., Danforth K.N., Brinton L.A., Moore S.C., Hollenbeck A.R., Schatzkin A., Lacey J.V. Body mass index and risk of ovarian cancer. Cancer 2009, 115:812-822.
33. Manabe Y., Toda S., Miyazaki K., Sugihara H. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. The Journal of Pathology 2003, 201:221-228.
34. Masamune A., Kikuta K., Watanabe T., Satoh K., Hirota M., Shimosegawa T. Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer. American Journal of Physiology - Gastrointestinal and Liver Physiology 2008, 295:G709-G717.
35. Nock N.L., Thompson C.L., Tucker T.C., Berger N.A., Li L. Associations between obesity and changes in adult BMI over time and colon cancer risk. Obesity (Silver Spring) 2008, 16:1099-1104.
36. Ogden C.L., Carroll M.D., Kit B.K., Flegal K.M. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. Journal of the American Medical Association 2012, 307:483-490.
37. Pichard C., Plu-Bureau G., Neves E.C.M., Gompel A. Insulin resistance, obesity and breast cancer risk. Maturitas 2008, 60:19-30.
38. Rau J.C., Beaulieu L.M., Huntington J.A., Church F.C. Serpins in thrombosis, hemostasis and fibrinolysis. Journal of Thrombosis and Haemostasis 2007, 5(Suppl. 1):102-115.
39. Samad F., Yamamoto K., Pandey M., Loskutoff D.J. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Molecular Medicine 1997, 3:37-48.
40. Samad F., Schneiderman J., Loskutoff D. Expression of fibrinolytic genes in tissues from human atherosclerotic aneurysms and from obese mice. Annals of the New York Academy of Sciences 1997, 811:350-358. discussion 358-60.
41. Schmitt M., Harbeck N., Thomssen C., Wilhelm O., Magdolen V., Reuning U., Ulm K., Hofler H., Janicke F., Graeff H. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thrombosis and Haemostasis 1997, 78:285-296.
42. Subbaramaiah K., Howe L.R., Bhardwaj P., Du B., Gravaghi C., Yantiss R.K., Zhou X.K., Blaho V.A., Hla T., Yang P., Kopelovich L., Hudis C.A., Dannenberg A.J. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prevention Research (Philadelphia, Pa.) 2011, 4:329-346.
43. Trayhurn P., Wood I.S. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochemical Society Transactions 2005, 33:1078-1081.
44. Wang B., Jenkins J.R., Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. American Journal of Physiology, Endocrinology and Metabolism 2005, 288:E731-E740.
45. Whitley B.R., Beaulieu L.M., Carter J.C., Church F.C. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells. Gynecologic Oncology 2007, 104:470-479.